HBOT Conversations:
Dr. Paul Harch & Traumatic Brain Injury

Dr. Paul G. Harch, M.D. has used hyperbaric oxygen therapy to treat more than 100 different conditions, including stroke, dementia, autism, and traumatic brain injury. His goal is to help his patients get their lives back using hyperbaric oxygen therapy.

He is the author of The Oxygen Revolution and is considered an International expert and pioneer in the field of Hyperbaric Oxygen Therapy (HBOT). His informative, and comprehensive guide on HBOT has helped countless souls better understand what HBOT is and how it directly affects the body at the genetic level.

This episode on Traumatic Brain Injury is the third in a nine episode series that will be released weekly with Dr. Harch.

Subscribe. Join the discussion. Share the hope.

Watch the Podcast

In episode 3 of 9, host Edward di Girolamo speaks with world renowned HBOT expert, Dr. Paul G. Harch on treating Traumatic Brain Injuries and PTSD with hyperbaric oxygen therapy.

di Girolamo starts the conversation telling a story about him, Sergeant Major Simon Lemay and retired Navy Captain Jim Hooker visiting the Durham VA, near Duke Hospital, in North Carolina. They had a sit-down meeting with three heads of the Psychiatry group at Veteran Affairs. They asked the question, “Does traumatic brain injury involve any sort of inflammation?” and the response they received was, “Next thing you’re going to tell me is that hyperbaric oxygen is good for every indication. And that’s when I glaze over and say I’m not interested in talking about it.” di Girolamo shakes his head at the negligence; and vocalizes his frustration that this powerful, natural anti-inflammatory treatment exists in hyperbaric oxygen therapy, and the VA won’t even consider learning more about the benefit of using it on veterans with a traumatic brain injury.

Harch agrees that the VA is completely oblivious to the evidence that HBOT works to treat inflammation and that inflammation absolutely exists as a result of PTSD and TBI. He explains that hyperbaric oxygen is highly effective for neurological applications, and it’s most effective in white matter diseases such as brain decompression illness, traumatic brain injury, and even in cases like multiple sclerosis and carbon monoxide poisoning.

Veteran suicides are a growing number that we must get under control. di Girolamo gives praise that at least the North Carolina Legislature acknowledged HBOT as an effective treatment for PTSD and TBI. Under Senate Bill 442 they allocated $150,000 to help veterans get 40 or more Hyperbaric Oxygen Therapy treatments. These veterans are improving like never before, lives are being saved and stories are being told.  They are finally getting their lives back, thanks to the power of Hyperbaric Oxygen Therapy!

But, how will HBOT help the average person – sport athlete, car accident victim, etc – with a concussion or TBI?  Dr. Harch refers to the brain like a head of broccoli sitting on its stem. If it’s shaken on the stem, then the torque forces cause the flimsy white matter tracks to be damaged and many of them can then divide, resulting in the formation of wounds. Essentially a bruise is formed on the brain…. and inflammation is present, even years later. But, when we expose that area to oxygen and pressure you now get gene stimulation, inhibition of inflammation, and stimulation of repair and growth of tissue. You start growing new axons, or nerve fibers, which is the cable transmission of neurons in the brain.

Dr. Harch stresses that if you or someone you know has recently had a brain injury, please find a hyperbaric facility as soon as possible.  If done early enough, the brain does not need too many HBOT treatments to repair itself; but if you wait years, when you’re still having headaches and other post-concussive syndrome symptoms, it could take 40 or more HBOT treatments to reverse the damage. Dr. Harch exclaims with confidence that HBOT is a “Slam Dunk” for TBI and PTSD recovery and 99% of the time it will absolutely help every patient who comes through his doors.

Subscribe Now, It’s Free !

[contact-form-7 id="65934" title="Subscribe"]

Guest

Dr. Paul G. Harch

Dr. Paul G. Harch, MD

Dr. Paul G. Harch, M.D. is a clinician in emergency medicine and hyperbaric medicine who is the former director of the University Medical Center Hyperbaric Medicine Department and LSU Hyperbaric Medicine Fellowship. Currently, he is a Clinical Professor of Medicine in the Section of Emergency Medicine at LSU School of Medicine in New Orleans. He graduated from the Johns Hopkins University School of Medicine after graduating from the University of California at Irvine with magna cum laude/Phi Beta Kappa honors.

Dr. Harch initiated and continues to be a private practice that has resulted in the largest case experience in neurological hyperbaric medicine in the world. In this practice, he adapted the concepts of conventional hyperbaric oxygen therapy to wounds in the central nervous system, which spawned the subsequent academic and research practice. Harch HBOT is the best place to receive oxygen therapy treatments, and patients have traveled from more than 50 countries to be treated by Dr. Harch himself.

Harch HBOT – Hyperbaric Oxygen Therapy Clinic

5216 Lapalco Blvd.
Marrero, LA
504-309-4948
hbot@hbot.com
https://hbot.com/

 

Recent HBOT News

Clinical Trial – the Use of Magnesium Sulfate for Prevention of Postspinal Shivering

Shivering is an unpleasant experience after spinal anesthesia. Shivering is defined as an
involuntary, repetitive activity of skeletal muscles. The mechanisms of shivering in patients
undergoing surgery are mainly intraoperative heat loss, increased sympathetic tone, pain, and
systemic release of pyrogens. Spinal anesthesia significantly impairs the thermoregulation
system by inhibiting tonic vasoconstriction, which plays a significant role in temperature
regulation. Spinal anesthesia also causes redistribution of core heat from the trunk (below
the block level) to the peripheral tissues. These two effects predispose patients to
hypothermia and shivering. The median incidence of shivering related to regional anesthesia
observed in a review of 21 studies is 55%. Shivering increases oxygen consumption, lactic
acidosis, carbon dioxide production, and metabolic rate by up to 400%. Therefore, shivering
may cause problems in patients with low cardiac and pulmonary reserves. The best way to avoid
these intraoperative and postoperative shivering-induced increases in hemodynamic and
metabolic demands is to prevent shivering in the first place. Although magnesium is among
several pharmacological agents used for the treatment of shivering, its effects on prevention
of shivering during central neuraxial blockade have not been evaluated to date. Henceforth,
the aim of this study was to evaluate the effect of magnesiume on shivering during spinal
anesthesia.

Aim:

to compare the efficacy of intravenous versus intrathecal magnesium sulphate for prevention
of post spinal shivering in adult patients undergoing elective lower limb orthopedic
surgeries.

Clinical Trial – Comparing the Effects of Levobupivacaine and Bupivacaine in Saddle Spinal Anesthesia

İn this study; it was aimed to investigate the effects of equipotent doses of hyperbaric
bupivacaine and hyperbaric levobupivacaine in outpatient anorectal surgery under saddle
block. Sixty patients between the age of 18- 50 and in the risk group of ASA I-II included in
the study. 7,5 mg of 0,5% hyperbaric bupivacaine or 7,5 mg of 0,5% hyperbaric levobupivacaine
injected into the intrathecal space in sitting position through L4-L5 or L5-S1 intervertebral
space in 30 seconds. All patients kept in sitting position for 5 minutes with aid after
intrathecal injection and than layed in supine position, finally they positioned in prone
jack-knife. Hemodynamic parameters like NIBP, HR, SpO2, sensory and motor block
characteristics, duration of analgesia, time of first voiding, mobilization time, patient and
surgeon satisfaction, adverse effects and discharge time were recorded during and after
surgery.